Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies

MLA

Matteo Lambertini, et al. “Prognostic and Clinical Impact of the Endocrine Resistance/Sensitivity Classification According to International Consensus Guidelines for Advanced Breast Cancer: An Individual Patient-Level Analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) Studies.” EClinicalMedicine, vol. 59, May 2023, p. 101931. EBSCOhost, https://doi.org/10.1016/j.eclinm.2023.101931.

APA

Matteo Lambertini, Eva Blondeaux, Giancarlo Bisagni, Silvia Mura, Sabino De Placido, Michelino De Laurentiis, Alessandra Fabi, Anita Rimanti, Andrea Michelotti, Mauro Mansutti, Antonio Russo, Filippo Montemurro, Antonio Frassoldati, Antonio Durando, Stefania Gori, Anna Turletti, Stefano Tamberi, Ylenia Urracci, Piero Fregatti, … Lucia Del Mastro. (2023). Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies. EClinicalMedicine, 59, 101931. https://doi.org/10.1016/j.eclinm.2023.101931

Chicago

Matteo Lambertini, Eva Blondeaux, Giancarlo Bisagni, Silvia Mura, Sabino De Placido, Michelino De Laurentiis, Alessandra Fabi, et al. 2023. “Prognostic and Clinical Impact of the Endocrine Resistance/Sensitivity Classification According to International Consensus Guidelines for Advanced Breast Cancer: An Individual Patient-Level Analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) Studies.” EClinicalMedicine 59 (May): 101931. doi:10.1016/j.eclinm.2023.101931.